Kerry Dooley Young

For health care journalists in the U.S., it’s important to understand the possible consequences of overturning the Chevron doctrine.

Pfizer withdrew its pill for sickle cell disease amid heightened European scrutiny, triggered by death rates seen in clinical studies.

A new analysis of tax benefits for nonprofit hospitals shows community contributions amid controversy over tax breaks for health systems.

CMS intends to speed payment decisions for as many as five "breakthrough" medical devices a year, potentially getting them to patients earlier.

For millions of Americans, the end of year means it's time to review health insurance coverage as open enrollment for 2025 gets underway. That usually takes place in October and November for the 154 million who get their plan through work; for the additional 21 million who access insurance through the government-run marketplaces created under the Affordable Care Act (ACA), it starts Nov. 1 and ends Dec. 15.

Politicians seek more involuntary treatment of homeless people with mental illness and addiction, but experts object to this approach.

Diabetic retinopathy appears to be more common in young people than earlier thought, leaving more of them at risk for eye damage that can result in vision loss, experts said.

Lawmakers Rush to Stave Off Doctor Pay Cuts as Medicare Finalizes 2025 Rates

Advances in tyrosine kinase inhibitors yielded robust options for CML, raising questions about US accelerated approval for the frontline use of asciminib in this indication.

Pharmacy benefit managers, created to negotiate better deals for consumers on medicines, instead have sometimes driven up drug prices.